James Thorne
Concure Oncology raises $3 million to advance Breast Microseed radioactive-seed treatment for early-stage breast cancer
Concure Oncology raised $3 million in a new SEC filing to fund its Breast Microseed brachytherapy treatment, which uses tiny radioactive titanium seeds to kill remaining cancer cells after tumor removal and prevent recurrence in early-stage breast cancer patients.
MontyCloud raises $2.85M seed led by Madrona to expand AI-driven multicloud management platform
MontyCloud, founded by cloud veterans from Microsoft, Amazon and others, raised $2.85 million in seed funding to expand its AI-driven multicloud management platform that currently supports AWS and plans to add Azure and other providers.
Quantivate raises undisclosed investment from Luminate Capital Partners; three Luminate partners join board
Quantivate, a Woodinville startup selling risk management and regulatory compliance software for regulated industries, raised an undisclosed funding round led solely by Luminate Capital Partners, which is placing three partners on Quantivate’s board. The company plans to use the partnership to accelerate product innovation, scale its team, and expand customer value in the growing GRC market.
Seattle Startup Picnic Raises $5M Seed Funding for Pizza-Making Robot Assembling 300 Pizzas Per Hour
Seattle startup Picnic raised $5 million in a seed round to advance their pizza-making robot, which can assemble 300 pizzas per hour and has attracted global interest. The funding will help develop the next version and expand pilot programs, addressing labor shortages in the food industry.
Seattle’s Tomorrow raises $8.9M to expand app for wills, trusts, guardianship and life insurance referrals
Seattle startup Tomorrow raised $8.9 million to expand an app that helps users create wills, trusts, assign guardians, and shop for life insurance, targeting an underserved end-of-life planning market.
Katalyst raises $5.6M led by Octopus Ventures to launch Peloton-style EMS at-home workout system
Seattle startup Katalyst raised $5.6 million to sell high-end hardware and subscription on-demand workouts that use full-body electrical muscle stimulation (EMS) for 20-minute low-impact strength sessions, positioning the product as a Peloton-like at-home fitness offering.
Chronosphere raises $11M Series A from Greylock to commercialize Uber’s M3 for multi-cloud metrics monitoring
Chronosphere, founded by ex-Microsoft and ex-Uber engineers Martin Mao and Rob Skillington, raised $11 million in Series A funding led by Greylock to build a cloud data monitoring and analytics platform based on Uber’s open-source M3 system, addressing scale and cost challenges from microservices and containers across AWS and Azure.
Seattle startup Ganaz raises $945,000 to scale text-based workforce management for agriculture and manufacturing
Seattle startup Ganaz raised $945,000 in new seed funding to expand a workforce-management platform that helps agriculture and manufacturing employers communicate with large numbers of largely blue-collar, often seasonal or foreign, workers via text and other tools aimed at onboarding, retention, payments, and remittances.
Leafly raises $2.3M convertible note while pausing most hiring and imposing company-wide cost controls after rapid doubling
Leafly raised $2.3 million via a convertible note but is instituting company-wide cost controls — pausing most hiring, cutting nonessential travel, and limiting spending — after doubling staff in seven months.
Twistle raises $16M Series A from Health Enterprise Partners and MemorialCare to automate hospital–patient communication
Twistle raised $16 million in a Series A led by Health Enterprise Partners and MemorialCare Innovation Fund to expand its platform that automates patient communication, education, and data collection for health systems. The company will use the funding to grow sales and invest in human-assisted automation as it competes with startups like Klara and Voalte and larger tech entrants such as Microsoft.
Cadence Neuroscience raises $15M Series A led by Jazz to develop Mayo Clinic–based implantable epilepsy device
Cadence Neuroscience raised $15 million in a Series A led by Jazz Venture Partners, plus support from Mayo Clinic and Epilepsy Foundation grants, to develop an implantable epilepsy therapy based on Mayo Clinic research. The Redmond startup hopes to leverage existing clinical data to accelerate development of a device aimed at patients whose seizures are not controlled by drugs.
Humana invests $20M in Accolade to expand joint 'Humana with Accolade' employee benefits platform
Humana invested $20 million in Seattle-based Accolade to expand a joint employee healthcare benefits offering called Humana with Accolade and to potentially collaborate on additional products that improve service delivery and economic value.
Outreach’s Manny Medina, Auth0’s Eugenio Pace, and Convoy’s Dan Lewis Share Team-Building, Mission, and Scaling Advice
At the GeekWire Summit, CEOs Manny Medina (Outreach), Eugenio Pace (Auth0), and Dan Lewis (Convoy) shared practical advice on building teams, defining meaningful missions, company values, and scaling sustainably. They emphasized attracting talent with a resonant mission, leading boldly into challenges, and growing without sacrificing core principles.
Komposite, led by Blue Origin and Intellectual Ventures alum Pablos Holman, raises $500,000 to build on-demand, digitally printed apparel
Seattle startup Komposite, led by inventor Pablos Holman, raised $500,000 to build an on-demand clothing business that prints colors and patterns digitally and only manufactures items after they’re sold to reduce waste and environmental impact.
Icosavax raises $51M Series A led by Qiming to build computer-designed VLP vaccines, starting with an adult RSV shot
Icosavax, a University of Washington spinout, raised $51 million in a Series A led by Qiming Venture Partners USA to develop computer-designed virus-like particle vaccines, starting with an adult RSV vaccine and planning broader applications.
Fred Hutch spinout SEngine Precision Medicine raises $5.1M Series A to commercialize PARIS tumor‑testing platform
SEngine Precision Medicine raised $5.1 million to commercialize its PARIS platform, which grows patients’ tumor cells in the lab to test safety and effectiveness of over 200 drugs or drug combinations and help match cancer patients to therapies. The company also gathers data for drug discovery, has a joint venture with Atomwise, and completed a Series A led by the Bangarang Group.
Axon hires ex-Amazon exec Jeff Kunins as Chief Product Officer; PayScale sees latest C-suite exit
Axon hired former Amazon executive Jeff Kunins as chief product officer and executive vice president of software, who will be based in Seattle; PayScale lost another senior executive as chief product and strategy officer Dave Smith departed amid several recent leadership exits. Startups Armoire and others added leaders too, with Armoire naming Berea Schaffer as head of product and technology after a $3.9 million seed round.
Fred Hutch spinout Faraday Pharmaceuticals raises $25M (up to $30M) to advance iodide drug preventing reperfusion injury and muscle loss
Faraday Pharmaceuticals, a Fred Hutch spinout, has raised $25 million (potentially up to $30 million) to develop an iodide-based drug to prevent reperfusion injury after heart attacks and ultimately limit skeletal muscle loss in stressed or bedridden patients.
UW Spinout Split Bio Raises $560,000 Bridge Round to Scale Whole Transcriptome Single‑Cell RNA‑Seq Kits, Total Funding Reaches $2M
University of Washington spinout Split Bio raised $560,000 in bridge financing to scale production of its Whole Transcriptome single-cell RNA sequencing kits, bringing total funding to $2 million. The startup—founded by Georg Seelig lab researchers Alex Rosenberg and Charles Roco—sells SPLiT-seq kits that don’t require custom instruments and aim to offer scalable, flexible sample processing.
Navigating Cancer raises $26M Series D from Merck GHIF and TT Capital to expand oncology patient-engagement platform
Seattle startup Navigating Cancer raised $26 million in a Series D led by Merck Global Health Innovation Fund and TT Capital Partners to expand its oncology patient engagement software and improve treatment adherence and outcomes.
Vector Capital buys meaningful stake in Windermere spinout MoxiWorks to fund expansion
MoxiWorks, a Seattle startup spun out of Windermere Real Estate, has sold a “meaningful” undisclosed stake to private equity firm Vector Capital to fund product development, sales and marketing, and potential acquisitions. Its brokerage-focused SaaS is used by 80 brokerages representing 130,000 agents, and Vector — which manages $4 billion — called MoxiWorks well positioned to capture the growing real estate technology market.
LumiThera raises $1.15M to advance Valeda photobiomodulation device for dry AMD, in U.S. trials and EU‑approved
LumiThera raised $1.15 million to advance its Valeda Light Delivery System, a photobiomodulation device aimed at improving and slowing vision loss in patients with dry age-related macular degeneration that is in U.S. clinical trials and approved for sale in the EU. The Poulsbo, Washington startup, co‑founded and led by CEO Clark Tedford, lists investors including Keiretsu Forum Northwest and executives with medical-device experience on its leadership team.
Group14 Technologies Raises $14.3M to Commercialize Silicon-Carbon Anode Materials for EV Batteries
Group14 Technologies, a three-year-old Seattle-area startup spun out of EnerG2, raised $14.3 million to develop silicon-carbon nanocomposite materials that boost electric-vehicle battery capacity by up to about 40% over graphite anodes.
Dumpling raises $3M led by Floodgate to build shopper-owned grocery delivery alternative to Instacart
Dumpling, a Seattle startup, raised $3 million led by Floodgate (with Fuel Capital) to build a personal-shopping platform that treats gig workers as independent business owners rather than anonymous contractors. The company aims to improve service and trust for high-value grocery items by letting shoppers set their own flat rates and add a personal touch.
AppViewX raises $30M Series A from Brighton Park Capital to expand low-code networking automation
AppViewX raised $30 million in a Series A from Brighton Park Capital to expand its low-code networking automation platform, which manages application delivery, certificate lifecycles and network security and integrates with cloud and vendor partners.